World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
36115
World Ranking
598
National Ranking
353

Medicine

D-Index
105
Citations
36157
World Ranking
6825
National Ranking
3603

Research.com Recognitions

  • 2012 - Fellow of the American Academy of Arts and Sciences
  • 2009 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2003 - Member of the National Academy of Medicine (NAM)
  • 1992 - E. Mead Johnson Award, Society for Pediatric Research
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Ann M. Arvin is affiliated with Stanford University in the United States. Their research spans multiple fields including Medicine, Immunology, and Microbiology, with a strong focus on Epidemiology, Infectious Diseases, and Immunology. Molecular Biology and Parasitology are also among their studied subfields.

The scientist's work covers a variety of topics related to viral infections and immunological responses. Key areas include Herpesvirus Infections and Treatments, Cytomegalovirus and herpesvirus research, Toxin Mechanisms and Immunotoxins, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Poxvirus research, and COVID-19 epidemiological studies.

Frequent co-authors collaborating with Ann M. Arvin include:

  • Stefan L. Oliver
  • Wah Chiu
  • Colin Havenar-Daughton
  • Antonio Lanzavecchia
  • Davide Corti

Publications have appeared in several venues, with repeated contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • PLoS Pathogens
  • Nature
  • The Journal of Infectious Diseases

Notable recent papers include:

  • "A perspective on potential antibody-dependent enhancement of SARS-CoV-2", 2020, Nature
  • "After the pandemic: perspectives on the future trajectory of COVID-19", 2021, Nature
  • "Prospects for a safe COVID-19 vaccine", 2020, Science Translational Medicine
  • "A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation", 2020, Nature Communications
  • "Target highlights in CASP14: Analysis of models by structure providers", 2021, Proteins Structure Function and Bioinformatics

Ann M. Arvin has contributed to academic literature beyond journal articles, including a book publication with Springer Science+Business Media titled "Varicella-zoster Virus" in 2022.

Awards and honors received include:

  • Fellow of the American Academy of Arts and Sciences, 2012
  • Fellow of the American Association for the Advancement of Science (AAAS), 2009
  • Member of the National Academy of Medicine (NAM), 2003
  • E. Mead Johnson Award, Society for Pediatric Research, 1992
  • Member of the Association of American Physicians

Best Publications

  • Varicella-zoster virus.

    Ann M. Arvin

  • Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

    Ann Arvin;Gabriella Campadelli-Fiume;Edward Mocarski;Patrick S. Moore

  • Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

    David W. Kimberlin;Chin Yu Lin;Richard F. Jacobs;Dwight A. Powell

  • Prevention of Transfusion-Acquired Cytomegalovirus Infections in Newborn Infants

    Anne S. Yeager;F. Carl Grumet;Elizabeth B. Hafleigh;Ann M. Arvin

  • Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era

    David W. Kimberlin;Chin-Yu Lin;Richard F. Jacobs;Dwight A. Powell

  • Intrauterine Infection with Varicella-Zoster Virus after Maternal Varicella

    Sharon G. Paryani;Ann M. Arvin

  • A perspective on potential antibody-dependent enhancement of SARS-CoV-2.

    Ann M. Arvin;Katja Fink;Michael A. Schmid;Andrea Cathcart

  • Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

    R Whitley;A Arvin;C Prober;L Corey

  • Molecular mechanisms of varicella zoster virus pathogenesis

    Leigh Zerboni;Nandini Sen;Stefan L. Oliver;Ann M. Arvin

  • A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection

    Whitley R;Arvin A;Prober C;Burchett S

  • Intrauterine herpes simplex virus infections

    Cecelia Hutto;Ann Arvin;Richard Jacobs;Russell Steele

  • Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee

    John F. Modlin;Ann M. Arvin;Patricia Fast;Martin Myers

  • Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.

    Atsuko Hata;Hideomi Asanuma;Mary Rinki;Margaret Sharp

  • After the pandemic: perspectives on the future trajectory of COVID-19.

    Amalio Telenti;Ann Arvin;Lawrence Corey;Davide Corti

  • Changing Presentation of Herpes Simplex Virus Infection in Neonates

    R J Whitley;L Corey;A Arvin;F D Lakeman

  • Low Risk of Herpes Simplex Virus Infections in Neonates Exposed to the Virus at the Time of Vaginal Delivery to Mothers with Recurrent Genital Herpes Simplex Virus Infections

    Prober Cg;Sullender Wm;Yasukawa Ll;Au Ds

  • Aging, immunity, and the varicella-zoster virus.

    Ann Arvin

  • Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

    Xiao-Song He;Tyson H. Holmes;Caiqiu Zhang;Kutubuddin Mahmood

  • A Controlled Trial of Acyclovir for Chickenpox in Normal Children

    Lisa M. Dunkle;Ann M. Arvin;Richard J. Whitley;Harley A. Rotbart

  • Deficiency of the Humoral Immune Response to Measles Vaccine in Infants Immunized at Age 6 Months

    Hayley A. Gans;Ann M. Arvin;Jill Galinus;Linda Logan

  • Predictors of Morbidity and Mortality in Neonates with Herpes Simplex Virus Infections

    R Whitley;A Arvin;C Prober;L Corey

  • Human Herpesviruses: Basic virology and viral gene effects on host cell functions: alphaherpesviruses

    Gabriella Campadelli-Fiume;Bernard Roizman

Frequent Co-Authors

Charles G. Prober
Charles G. Prober Stanford University
Richard J. Whitley
Richard J. Whitley University of Alabama at Birmingham
Harry B. Greenberg
Harry B. Greenberg Stanford University
Anne A. Gershon
Anne A. Gershon Columbia University
Thomas C. Merigan
Thomas C. Merigan Stanford University
Charles Grose
Charles Grose University of Iowa
Cornelia L. Dekker
Cornelia L. Dekker Stanford University
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
George Kemble
George Kemble Sagimet Biosciences
Xiao-Song He
Xiao-Song He University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology but seeking alternative or complementary career paths in healthcare, several online degree options can provide a solid foundation. For individuals without a nursing background, exploring online BSN programs for non nurses can be an excellent starting point. These programs equip students with essential nursing knowledge and clinical skills.

If you want a quicker route into nursing, consider the easiest ABSN programs to get into. These accelerated BSN programs are structured to fast-track your education, making it possible to enter the field sooner.

For those looking for practical nursing roles, exploring the fastest and easiest LPN programs offers a way to quickly acquire licensure and begin working in supportive nursing capacities.

Lastly, if advancing to higher clinical responsibilities is your goal, investigating the easiest online nurse practitioner programs can guide you toward specialized roles that blend patient care and advanced scientific knowledge—a path that parallels the analytical focus of immunology.

Best Scientists Citing Ann M. Arvin

Trending Scientists